Beta Bionics (BBNX) Equity Average (2024 - 2026)
Beta Bionics' Equity Average history spans 3 years, with the latest figure at $279.4 million for Q1 2026.
- On a quarterly basis, Equity Average rose 717.14% to $279.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $279.4 million, a 717.14% increase, with the full-year FY2025 number at $21.1 million, up 109.42% from a year prior.
- Equity Average hit $279.4 million in Q1 2026 for Beta Bionics, down from $291.2 million in the prior quarter.
- Over the last five years, Equity Average for BBNX hit a ceiling of $307.7 million in Q2 2025 and a floor of -$237.1 million in Q4 2024.
- Historically, Equity Average has averaged $35.8 million across 3 years, with a median of $34.2 million in 2025.
- Biggest five-year swings in Equity Average: soared 116.38% in 2025 and later surged 717.14% in 2026.
- Tracing BBNX's Equity Average over 3 years: stood at -$237.1 million in 2024, then skyrocketed by 222.81% to $291.2 million in 2025, then fell by 4.04% to $279.4 million in 2026.
- Business Quant data shows Equity Average for BBNX at $279.4 million in Q1 2026, $291.2 million in Q4 2025, and $298.2 million in Q3 2025.